XML 34 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
6 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Operating Activities:    
Net income $ 22,058 $ 5,348,895
Less: Net income from discontinued operations (Note 16)   81,625
(Loss) income from continuing operations 22,058 5,267,270
Adjustments to reconcile net income to net cash provided by operating activities of continuing operations:    
Depreciation and amortization 45,011 83,992
Provision for doubtful accounts   (24,000)
Warranty provision (40,007) 106,258
Inventory obsolescence (98,686) 18,861
Share-based compensation 277,470 210,670
Loss on impairment of patents 11,197 20,433
Changes in operating assets and liabilities:    
Restricted cash (39,406) (3,031,250)
Accounts receivable 2,964,885 1,797,555
Inventories (358,497) (513,522)
Prepaid expenses and other 72,530 (593,651)
Prepaid expenses - noncurrent 62,390 (1,312,500)
Accounts payable (602,704) (106,583)
Warranty settlements (15,014) (21,327)
Accrued liabilities (2,261,030) (439,871)
Net provided by operating activities of continuing operations 40,197 1,462,335
Net cash (used in) provided by operating activities of discontinued operations (Note 16) (3,013) 79,037
Net cash provided by operating activities 37,184 1,541,372
Investing Activities:    
Purchase of equipment (22,342) (21,859)
Patent costs paid (832) (761)
Net cash used in investing activities (23,174) (22,620)
Financing Activities:    
Proceeds from exercise of common stock warrants   4,346,613
Proceeds from exercise of stock options   109,910
Net cash provided by financing activities   4,456,523
Net increase in cash and cash equivalents 14,010 5,975,275
Cash and cash equivalents, beginning of period 13,870,762 5,421,167
Cash and cash equivalents, end of period 13,884,772 11,396,442
Supplemental Disclosure of Cash Flow Information    
Cash paid for taxes $ 60,015 $ 209,550